Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

CTNM vs EWTX: stock comparison and AI forecast

Contineum Therapeutics, Inc. (CTNM) and Edgewise Therapeutics, Inc. (EWTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

CTNM Contineum Therapeutics, Inc.

Market Cap
$360M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

EWTX Edgewise Therapeutics, Inc.

Price
$38.11 +21.2% · 6M
Market Cap
$4.14B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CTNM · EWTX

Key facts

  • EWTX is 11.5 times larger than CTNM by market capitalization ($4.14B against $360M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCTNMEWTX
Market Cap$360M$4.14B
P/B Ratio–9.24x
EPS$-3.14$-1.82
Book Value/Share–$4.13
FCF/Share$-1.42$-1.46

Profitability & Margins

MetricCTNMEWTX
ROE–-44.0%
ROA–-41.1%
ROIC–-48.6%
Tax Rate0.0%–

Financial Health

MetricCTNMEWTX
Current Ratio37.17x16.24x
D/E Ratio–0.07x
Financial Leverage–1.07x
Working Capital$236M$442M

Cash Flow

MetricCTNMEWTX
Operating Cash Flow-$53M-$158M
Free Cash Flow-$53M-$159M
Capital Spending-$460K-$550K

Income Statement

MetricCTNMEWTX
Operating Income-$66M-$219M
Net Income–-$197M
R&D Expense$48M$171M

Dividend & Shareholder Information

MetricCTNMEWTX
Shares Outstanding38M109M
FAQ

CTNM vs EWTX: stock comparison and AI forecast

Which is bigger, CTNM or EWTX?

EWTX is 11.5 times larger than CTNM by market capitalization ($4.14B against $360M).

Which one does Intratio's AI model rank higher, CTNM or EWTX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.